MECLIZINE HYDROCHLORIDE- meclizine hcl tablet, chewable 
NORTHEAST PHARMA

----------

hpc 779

Active ingredient (in each chewable tablet)

Meclizine HCl 25 mg

Purpose

Antiemetic

Uses

For the prevention and treatment of these symptoms associated
with motion sickness • nausea • vomiting • dizziness

Warnings

Do not use

for children under 12 years of age unless directed by a doctor.

Ask a doctor before use if you have

  • glaucoma
  • breathing problems, such as emphysema or chronic bronchitis
  • difficulty urinating due to an enlarged prostate gland

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers.

When using this product

  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • drowsiness may occur
  • avoid alcoholic beverages 
  • use caution when driving a motor vehicle or operating machinery 

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

corn starch, FD&C red #40 aluminum lake, flavor, lactose anhydrous, magnesium stearate, saccharin sodium, silicon dioxide

Questions or comments?

1-800-540-3765

Principal Display Panel

1

MECLIZINE HYDROCHLORIDE 
meclizine hcl tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:80136-779
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
STARCH, CORN (UNII: O8232NY3SJ)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorpinkScore2 pieces
ShapeROUNDSize9mm
FlavorRASPBERRYImprint Code 44;404
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:80136-779-01100 in 1 BOTTLE; Type 0: Not a Combination Product11/01/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00911/01/2022
Labeler - NORTHEAST PHARMA (081232935)
Registrant - GERI-CARE PHARMACEUTICAL CORP (611196254)

Revised: 10/2023
Document Id: 08a175ae-230a-ef8d-e063-6394a90ad234
Set id: eea1e7ec-1cdf-02e3-e053-2a95a90aed44
Version: 2
Effective Time: 20231026
 
NORTHEAST PHARMA